Valuation: Mecure Industries PLC

Market Cap 225B 169M 147M 139M 127M 237M 16.19B 238M 1.66B 642M 8.23B 635M 621M 26.35B P/E 2024
23.9x
P/E 2025 40.4x
Enterprise Value 274B 206M 179M 170M 154M 288M 19.71B 289M 2.02B 781M 10.02B 773M 756M 32.07B EV / Sales 2024
1.99x
EV / Sales 2025 3.99x
Free-Float
12.71%
Yield 2024
1.08%
Yield 2025 0.49%
3 months-40.78%
6 months-8.62%
Current year-13.80%
1 week 56.2
Extreme 56.2
56.2
1 month 56.2
Extreme 56.2
56.2
Current year 54.55
Extreme 54.55
104
1 year 21.6
Extreme 21.6
104
3 years 5.73
Extreme 5.73
104
5 years 5.73
Extreme 5.73
104
10 years 5.73
Extreme 5.73
104
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+160.19% - 169M
+1.55%+1.69%+81.35%+36.86% 363B
-0.04%+0.08%+22.43%-18.19% 65.62B
+1.14%+2.50%+44.68%+179.65% 12.45B
-0.29%+2.94%-6.00%-16.51% 7.6B
+1.28%-5.04%-26.26%-13.25% 4.49B
+0.26%-1.77%-33.30%+7.78% 4.19B
-1.48%+0.87%-32.20%-15.17% 2.92B
+3.72%+2.95%-4.20%+46.84% 2.49B
-0.77%-0.30%-27.96%-33.50% 1.93B
Average +0.53%+1.06%+17.87%+19.39% 46.49B
Weighted average by Cap. +1.25%+1.42%+66.96%+30.73%

Financials

2024 2025
Net sales 46.03B 34.62M 30.15M 28.54M 25.93M 48.44M 3.32B 48.68M 340M 131M 1.68B 130M 127M 5.39B 77.69B 58.44M 50.9M 48.17M 43.77M 81.77M 5.6B 82.17M 574M 222M 2.84B 220M 215M 9.11B
Net income 2.33B 1.75M 1.53M 1.44M 1.31M 2.45M 168M 2.46M 17.2M 6.65M 85.25M 6.58M 6.43M 273M 6.46B 4.86M 4.23M 4.01M 3.64M 6.8M 466M 6.83M 47.73M 18.45M 237M 18.26M 17.85M 757M
Net Debt 35.77B 26.9M 23.43M 22.18M 20.15M 37.65M 2.58B 37.83M 264M 102M 1.31B 101M 98.82M 4.19B 48.85B 36.75M 32.01M 30.29M 27.52M 51.41M 3.52B 51.67M 361M 140M 1.79B 138M 135M 5.73B
Logo Mecure Industries PLC
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.
Employees
195
Date Price Change Volume
17/09/26 NGN 56.20 0.00% 228,949
16/09/26 NGN 56.20 0.00% 100,274
15/09/26 NGN 56.20 0.00% 293,670
14/09/26 NGN 56.20 0.00% 72,809
11/09/26 NGN 56.20 0.00% 77,942
  1. Stock Market
  2. Stocks
  3. MECURE Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!